Americord collects, processes and stores newborns' cord blood for future medical or therapeutic use. In addition to cord blood banking, we also offer a proprietary process, called CordAdvantage (available later this year), which harvests stem cells from the placenta in addition to the umbilical cord blood. CordAdvantage may save many times more stem cells than cord blood banking alone. Americord is registered with the FDA and the company's laboratory is accredited by the AABB.
Americord is a family bank
For cord blood, there are two types of banks: family banks (for one's own family's use, such as Americord) and public donor banks (for unrelated or non-family use i.e. "public"). While every parent has the option of saving placental and umbilical cord blood stem cells for their baby and family with a family bank, only a small number of people may be able to donate their baby's stem cells to a public bank. Cord blood collection for public donation is only available at specified hospitals in limited regional locations, primarily because of limited funding of public banks.
In addition, many families are ineligible for donation for a variety of reasons including family health history, maternal exposure to viruses, and international travel.
Americord is different from a typical cord blood bank
Americord's CordAdvantage product, which will be available later this year, harvests stem cells from the placenta in addition to the umbilical cord blood that may preserve many times more stem cells than umbilical cord blood banking alone. The increased volume of stem cells that Americord can preserve is absolutely critical because while stem cells are already being used to treat nearly 80 diseases, there are simply not enough stem cells in cord blood alone to treat an adult sized patient.
Pioneered by Americord, CordAdvantage (available later this year) is a proprietary, patent-pending process that uses an FDA-approved drug to harvest a significant amount of stem cells from the placental cord blood in addition to harvesting stem cells from the umbilical cord blood. Most cord blood banks do not offer placenta collection. One of our competitors who does uses a rinsing technique, called perfusion, to rinse the remaining cord blood from the placental blood vessels. However, independent studies have shown that perfusion produced less than 20% more stem cells than can be harvested from umbilical cord blood alone. CordAdvantage, in comparison, preserves many times more stem cells as compared to traditional umbilical cord blood banking. CordAdvantage is by far the most valuable and effective method for preserving the maximum amount of stem cells available from your newborn baby.
Once you make the decision to preserve cord blood or cord tissue stem cells, compare Americord to the other leading cord blood banking and cord tissue banking companies, such as Viacord or CBR. We provide the highest quality service available. And our cord blood and cord tissue prices are very competitive.